跨国药企如阿斯利康、罗氏等看好中国市场,加速创新药引进布局。多家企业计划在未来几年内引入数十款创新药物,以满足中国老龄化带来的旺盛医药需求,同时国内鼓励创新政策也为创新药发展提供了支持。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.